JPMorgan Chase & Co’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-30,552
| Closed | -$9.67M | – | 6777 |
|
|
2023
Q4 | $9.67M | Sell |
30,552
-3,675
| -11% | -$1.16M | ﹤0.01% | 2128 |
|
|
2023
Q3 | $5.79M | Sell |
34,227
-27,516
| -45% | -$4.65M | ﹤0.01% | 2338 |
|
|
2023
Q2 | $13.4M | Buy |
61,743
+9,086
| +17% | +$1.97M | ﹤0.01% | 1822 |
|
|
2023
Q1 | $9.56M | Buy |
52,657
+16,045
| +44% | +$2.91M | ﹤0.01% | 2035 |
|
|
2022
Q4 | $7.2M | Buy |
36,612
+3,315
| +10% | +$651K | ﹤0.01% | 2142 |
|
|
2022
Q3 | $7.49M | Buy |
33,297
+9,331
| +39% | +$2.1M | ﹤0.01% | 2068 |
|
|
2022
Q2 | $3.03M | Buy |
23,966
+3,748
| +19% | +$474K | ﹤0.01% | 2744 |
|
|
2022
Q1 | $2.56M | Buy |
20,218
+3,317
| +20% | +$420K | ﹤0.01% | 3011 |
|
|
2021
Q4 | $2.21M | Buy |
16,901
+1,388
| +9% | +$182K | ﹤0.01% | 3167 |
|
|
2021
Q3 | $1.9M | Buy |
15,513
+1,231
| +9% | +$151K | ﹤0.01% | 3221 |
|
|
2021
Q2 | $1.63M | Buy |
14,282
+4,181
| +41% | +$477K | ﹤0.01% | 3336 |
|
|
2021
Q1 | $1.21M | Buy |
10,101
+2,976
| +42% | +$358K | ﹤0.01% | 3544 |
|
|
2020
Q4 | $724K | Buy |
7,125
+1,236
| +21% | +$126K | ﹤0.01% | 3550 |
|
|
2020
Q3 | $465K | Buy |
5,889
+661
| +13% | +$52.2K | ﹤0.01% | 3415 |
|
|
2020
Q2 | $582K | Buy |
5,228
+1,841
| +54% | +$205K | ﹤0.01% | 3247 |
|
|
2020
Q1 | $244K | Buy |
3,387
+1,884
| +125% | +$136K | ﹤0.01% | 3630 |
|
|
2019
Q4 | $113K | Sell |
1,503
-506
| -25% | -$38K | ﹤0.01% | 3981 |
|
|
2019
Q3 | $32K | Sell |
2,009
-25,040
| -93% | -$399K | ﹤0.01% | 4384 |
|
|
2019
Q2 | $542K | Buy |
+27,049
| New | +$542K | ﹤0.01% | 3343 |
|